<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01978678</url>
  </required_header>
  <id_info>
    <org_study_id>Aperitif</org_study_id>
    <nct_id>NCT01978678</nct_id>
  </id_info>
  <brief_title>Does Asthma Phenotype Have Impact on Disease Control</brief_title>
  <acronym>Aperitif</acronym>
  <official_title>Does Asthma Phenotype Have Impact on Disease Control - Can Detection of Inflammation and Hyper Responsiveness Ensure Stable Disease Faster</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The application of biomarkers that are more closely associated with eosinophillic airway
      inflammation, such as measurements of FeNO level, cell count in induced sputum or bronchial
      reactivity could improve asthma control by better directing treatment. A systematic review
      and meta-analysis is to be conducted to assess the efficacy of tailoring asthma intervention
      on clinical symptoms compared with exhaled nitric oxide or induced sputum count.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AHR used as outcome
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Control of asthma based on an algorithm</measure>
    <time_frame>2 years</time_frame>
    <description>Based on ACQ and FeNO</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The use of NO and sputum cell count as a marker in asthma management</measure>
    <time_frame>2 years</time_frame>
    <description>Based on ACQ and FeNO</description>
  </secondary_outcome>
  <other_outcome>
    <measure>the use of ACQ and miniAQLQ</measure>
    <time_frame>2 years</time_frame>
    <description>Based on ACQ and FeNO</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Pulmicort</arm_group_label>
    <description>ICS and LABA - based on ACQ and FeNO</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pulmicort</intervention_name>
    <description>ACQ and FeNO</description>
    <arm_group_label>Pulmicort</arm_group_label>
    <other_name>RCT study</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newly referred asthma patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  positiv mannitol

          -  asthma diagnose

        Exclusion Criteria:

          -  other lung disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vibeke Backer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Respiratory Medicine, L, Bispebjerg Hospital,</name>
      <address>
        <city>Copenhagen</city>
        <state>NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Respiratory research unit, Bispebjerg University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>November 1, 2013</study_first_submitted>
  <study_first_submitted_qc>November 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2013</study_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Vibeke Backer</investigator_full_name>
    <investigator_title>DmSci, professor, md</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

